0001832885-21-000037.txt : 20210614 0001832885-21-000037.hdr.sgml : 20210614 20210614152251 ACCESSION NUMBER: 0001832885-21-000037 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 EFFECTIVENESS DATE: 20210614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solas BioVentures Fund II, LP CENTRAL INDEX KEY: 0001813747 IRS NUMBER: 850627769 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-369247 FILM NUMBER: 211014404 BUSINESS ADDRESS: STREET 1: 835 GEORGIA AVENUE STREET 2: SUITE 800 CITY: CHATTANOOGA STATE: TN ZIP: 37402 BUSINESS PHONE: (423) 648-7894 MAIL ADDRESS: STREET 1: 835 GEORGIA AVENUE STREET 2: SUITE 800 CITY: CHATTANOOGA STATE: TN ZIP: 37402 D/A 1 primary_doc.xml X0708 D/A LIVE 0001813747 Solas BioVentures Fund II, LP 835 GEORGIA AVENUE412 GEORGIA AVENUE Suite 201 CHATTANOOGA TN TENNESSEE 37403 (423) 243-3460 DELAWARE None None Limited Partnership true 2020 Mark N/A Hackett 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN TENNESSEE 37403 Executive Officer Promoter Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer Michael N/A Hoey 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN TENNESSEE 37403 Executive Officer Promoter Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer Charles David Adair 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN TENNESSEE 37403 Executive Officer Promoter Manager of Solas BioVentures Management LLC, the Investment Manager of the Issuer N/A N/A Solas Partners II, LLC 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN TENNESSEE 37403 Promoter General Partner of Issuer N/A N/A Solas BioVentures Management, LLC 412 GEORGIA AVENUE SUITE 201 CHATTANOOGA TN TENNESSEE 37403 Promoter Investment Manager of Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 true 0001813747-20-000001 2020-06-05 true true false 500000 Indefinite 27710000 Indefinite false 76 0 true 0 true 250000 true The Issuer's organizational expenses will be reimbursed by the Issuer to the General Partner and/or Investment Manager. The Investment Manager will receive an annual management fee from the Issuer as described in the Issuer's offering documents false Solas BioVentures Fund II, LP Mark Hackett Mark Hackett Manager 2021-06-11